COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth

Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections https://bit.ly/3cnEFvg

Guardat en:
Dades bibliogràfiques
Publicat a:ERJ Open Res
Autors principals: Renner, Andreas, Marth, Katharina, Patocka, Karin, Idzko, Marco, Pohl, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: European Respiratory Society 2020
Matèries:
Original Research Letters
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569753/
https://ncbi.nlm.nih.gov/pubmed/33257916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00457-2020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars